Levodopa/Carbidopa/Entacapone Abz

Levodopa, Carbidopa, Entacapone, the active ingredient in Levodopa/Carbidopa/Entacapone Abz, is a combination dopamine precursor and COMT inhibitor presented as a tablet for oral use. It treats Parkinson's disease and Parkinson's disease with motor fluctuations.

GNH USA supplies Levodopa/Carbidopa/Entacapone Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is used in the management of Parkinsonian disorders and related motor complications. - Parkinson's disease: improves overall motor symptoms such as bradykinesia, rigidity and tremor. - Parkinson's disease with motor fluctuations: reduces "off" periods and prolongs "on" time without troublesome dyskinesia.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Dry mouth: reduced salivation. - Insomnia: difficulty falling or staying asleep. - Orthostatic hypotension: drop in blood pressure on standing. - Vomiting: occasional severe nausea.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked blood‑pressure fall requiring medical attention. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe depression or suicidal thoughts. - Allergic reactions: rash, angioedema, or anaphylaxis.

Before prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety measures. - Blood pressure monitoring: watch for orthostatic hypotension, especially at therapy initiation. - Psychiatric assessment: evaluate for hallucinations, confusion, or depression. - Renal/hepatic function: dose may need adjustment in impairment. - Cardiovascular disease: use caution in patients with arrhythmias or ischemic heart disease. - Abrupt discontinuation: taper gradually to avoid withdrawal symptoms. - Store at room temperature: keep in the original container, protect from moisture and light.

Levodopa/Carbidopa/Entacapone interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Selective MAO‑B inhibitors (e.g., selegiline): may cause severe hypertension. - Antipsychotics (e.g., haloperidol): can diminish antiparkinson effect. - Iron or antacid preparations: reduce levodopa absorption.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: may increase risk of serotonin syndrome. - Tricyclic antidepressants: may enhance orthostatic hypotension. - Diuretics: additive blood‑pressure lowering effect.